Top Healthcare companies in United States by EBT Margin

This ranking features the top 470 Healthcare companies in United States ranked by EBT Margin, averaging a EBT Margin of -7,500.36%, for February 04, 2025.

United States

Healthcare

#	Name	EBT Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,778.84%	Sept. 30, 2024	USD 12.72	-6.33%	United States
2	Agios Pharmaceuticals, Inc. 2 AGIO	2,212.98%	Sept. 30, 2024	USD 33.62	-2.24%	United States
3	Maravai LifeSciences Holdings, Inc. 3 MRVI	159.33%	Sept. 30, 2024	USD 4.94	0.20%	United States
4	Royalty Pharma plc 4 RPRX	72.22%	Dec. 31, 2023	USD 31.33	-0.79%	United States
5	SIGA Technologies, Inc. 5 SIGA	63.52%	Sept. 30, 2024	USD 5.78	-3.34%	United States
6	Protagonist Therapeutics, Inc. 6 PTGX	53.45%	Sept. 30, 2024	USD 37.20	-1.59%	United States
7	United Therapeutics Corporation 7 UTHR	52.17%	Sept. 30, 2024	USD 354.58	0.97%	United States
8	Halozyme Therapeutics, Inc. 8 HALO	50.68%	Sept. 30, 2024	USD 56.28	-0.64%	United States
9	Doximity, Inc. 9 DOCS	43.79%	Sept. 30, 2024	USD 59.10	NA	United States
10	Utah Medical Products, Inc. 10 UTMD	41.30%	Sept. 30, 2024	USD 59.92	-2.14%	United States
11	Catalyst Pharmaceuticals, Inc. 11 CPRX	41.00%	Sept. 30, 2024	USD 22.62	0.27%	United States
12	Lantheus Holdings, Inc. 12 LNTH	38.09%	Sept. 30, 2024	USD 89.54	-3.21%	United States
13	Regeneron Pharmaceuticals, Inc. 13 REGN	35.89%	Sept. 30, 2024	USD 666.85	-0.91%	United States
14	Entrada Therapeutics, Inc. 14 TRDA	35.51%	Sept. 30, 2024	USD 13.33	-0.82%	United States
15	IRadimed Corporation 15 IRMD	33.12%	Sept. 30, 2024	USD 59.35	0.24%	United States
16	ResMed Inc. 16 RMD	31.16%	Dec. 31, 2024	USD 240.55	1.85%	United States
17	Semler Scientific, Inc. 17 SMLR	30.75%	Sept. 30, 2024	USD 50.46	-2.89%	United States
18	Intuitive Surgical, Inc. 18 ISRG	30.25%	Sept. 30, 2024	USD 578.55	1.17%	United States
19	Exelixis, Inc. 19 EXEL	28.82%	Sept. 27, 2024	USD 32.88	-0.81%	United States
20	Roper Technologies, Inc. 20 ROP	27.95%	Dec. 31, 2024	USD 577.04	0.24%	United States
21	Edwards Lifesciences Corporation 21 EW	27.59%	Sept. 30, 2024	USD 71.38	-1.48%	United States
22	Corcept Therapeutics Incorporated 22 CORT	26.46%	Sept. 30, 2024	USD 66.55	-0.55%	United States
23	Amphastar Pharmaceuticals, Inc. 23 AMPH	25.95%	Sept. 30, 2024	USD 33.39	-4.24%	United States
24	Harmony Biosciences Holdings, Inc. 24 HRMY	25.71%	Sept. 30, 2024	USD 38.70	-0.18%	United States
25	LeMaitre Vascular, Inc. 25 LMAT	25.43%	Sept. 30, 2024	USD 95.43	-1.55%	United States
26	Eli Lilly and Company 26 LLY	24.84%	Sept. 30, 2024	USD 810.43	-0.08%	United States
27	Waters Corporation 27 WAT	24.63%	Sept. 28, 2024	USD 411.19	-1.03%	United States
28	National Research Corporation 28 NRC	24.48%	Sept. 30, 2024	USD 16.36	-1.86%	United States
29	Tenet Healthcare Corporation 29 THC	24.38%	Sept. 30, 2024	USD 144.64	2.66%	United States
30	Krystal Biotech, Inc. 30 KRYS	23.77%	Sept. 30, 2024	USD 159.03	-0.44%	United States
31	Agilent Technologies, Inc. 31 A	23.36%	Oct. 31, 2024	USD 148.63	-1.91%	United States
32	Neurocrine Biosciences, Inc. 32 NBIX	23.26%	Sept. 30, 2024	USD 150.10	-1.13%	United States
33	Merck & Co., Inc. 33 MRK	21.70%	Sept. 30, 2024	USD 99.79	0.98%	United States
34	Hologic, Inc. 34 HOLX	21.47%	Sept. 28, 2024	USD 71.72	-0.58%	United States
35	Collegium Pharmaceutical, Inc. 35 COLL	21.36%	Sept. 30, 2024	USD 31.20	-2.86%	United States
36	Medpace Holdings, Inc. 36 MEDP	20.90%	Sept. 30, 2024	USD 343.38	-1.65%	United States
37	MiMedx Group, Inc. 37 MDXG	20.82%	Sept. 30, 2024	USD 8.54	-1.84%	United States
38	West Pharmaceutical Services, Inc. 38 WST	20.47%	Sept. 30, 2024	USD 337.03	-1.32%	United States
39	Innoviva, Inc. 39 INVA	20.35%	Sept. 30, 2024	USD 18.41	-1.23%	United States
40	Biogen Inc. 40 BIIB	20.27%	Sept. 30, 2024	USD 142.34	-1.10%	United States
41	Johnson & Johnson 41 JNJ	20.10%	Sept. 29, 2024	USD 151.87	-0.18%	United States
42	Danaher Corporation 42 DHR	19.46%	Dec. 31, 2024	USD 214.26	-3.81%	United States
43	ADMA Biologics, Inc. 43 ADMA	19.16%	Sept. 30, 2024	USD 16.47	1.98%	United States
44	Ironwood Pharmaceuticals, Inc. 44 IRWD	18.91%	Sept. 30, 2024	USD 2.10	-10.47%	United States
45	DexCom, Inc. 45 DXCM	18.81%	Sept. 30, 2024	USD 87.05	0.25%	United States
46	Fortive Corporation 46 FTV	17.49%	Sept. 27, 2024	USD 80.24	-1.34%	United States
47	FONAR Corporation 47 FONR	17.14%	Sept. 30, 2024	USD 15.53	-1.40%	United States
48	Abbott Laboratories 48 ABT	16.44%	Sept. 30, 2024	USD 128.45	0.41%	United States
49	Thermo Fisher Scientific Inc. 49 TMO	16.41%	Dec. 31, 2024	USD 593.75	-0.67%	United States
50	Insulet Corporation 50 PODD	16.37%	Sept. 30, 2024	USD 278.90	0.19%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Healthcare company in United States has the highest EBT Margin ?

The Healthcare company in United States with the highest EBT Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,778.84%.
Which Healthcare company in United States has the lowest EBT Margin ?

The Healthcare company in United States with the lowest EBT Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Healthcare companies in United States by EBT Margin ?

The top 10 Healthcare companies in United States by EBT Margin are Inhibrx Biosciences, Inc., Agios Pharmaceuticals, Inc., Maravai LifeSciences Holdings, Inc., Royalty Pharma plc, SIGA Technologies, Inc., Protagonist Therapeutics, Inc., United Therapeutics Corporation, Halozyme Therapeutics, Inc., Doximity, Inc. and Utah Medical Products, Inc..
What are the bottom 10 Healthcare companies in United States by EBT Margin ?

The bottom 10 Healthcare companies in United States by EBT Margin are Inhibikase Therapeutics, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Altimmune, Inc., Greenwich LifeSciences, Inc., Allogene Therapeutics, Inc., Acelyrin, Inc., 89bio, Inc. and INmune Bio, Inc..

Frequently Asked Questions

Don’t Miss A Beat